Skip to main content
Addgene

HA-VHL 1-187-pRc/CMV
(Plasmid #22079)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 22079 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pRc/CMV
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 5447
  • Vector type
    Mammalian Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Growth instructions
    DH5 alpha or XL1 @ 37˚C
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    von Hippel-Lindau tumor suppressor (VHL)
  • Alt name
    vHL
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    626
  • Mutation
    deletion mutant covering only aa 1-187 of wt VHL (1-213) thus lacking the 26 c-terminal aa
  • GenBank ID
    NM_000551
  • Entrez Gene
    VHL (a.k.a. HRCA1, RCA1, VHL1, pVHL)
  • Tag / Fusion Protein
    • HA-tag (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site Hind III (destroyed during cloning)
  • 3′ cloning site Xba I (destroyed during cloning)
  • 5′ sequencing primer T7
  • 3′ sequencing primer SP6
    • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    HA-VHL 1-187-pRc/CMV was a gift from William Kaelin (Addgene plasmid # 22079 ; http://n2t.net/addgene:22079 ; RRID:Addgene_22079)

  • For your References section:

    Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG. Mol Cell Biol. 1998 Feb . 18(2):732-41. PubMed 9447969
Related items:
Commonly requested with: